Middle East and Africa infusion (elastomeric) pumps market is projected to register a substantial CAGR of 9.5 % in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2020, the base year of calculation is 2021 and the forecast period is 2022 to 2029.
Market Segmentation:
Middle East and Africa Infusion (Elastomeric) Pump Market, By Product Type (Elastomeric Infusion Pumps, Accessories and Consumables, and Other Accessories and Consumables), Route of Administration (Subcutaneous, Intravenous, Intramuscular, and Epidural), Application (Antibiotic/Antiviral Therapy, Pain Management, Chemotherapy, Thalassemia Treatment, Diuretics Treatment, Long Term Infusion Treatment, Other Applications), End User (Hospitals, Specialty Clinics, Laboratories, Ambulatory Care Setting, Academic and Research Institutes, Home Care Settings and Others), Distribution Channel (Direct Tender, Retail Sales, Online Sales, and Others), Country (South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2029.
Some of the major factors contributing to the growth of the Middle East and Africa infusion (elastomeric) pump market are:
Increasing incidence of chronic diseases
Increased adoption of ambulatory pumps in home care settings
Increased technological advancements in infusion (elastomeric) pumps system
Market Players:
Some of the key market players for the Middle East and Africa infusion (elastomeric) pump market are listed below:
B. Braun SE
ICU Medical
Werfen
NIPRO
Baxter
Others
TABLE OF CONTENTS
1 INTRODUCTION 15
- 1.1 OBJECTIVES OF THE STUDY 15
- 1.2 MARKET DEFINITION 15
- 1.3 OVERVIEW OF MIDDLE EAST AND AFRICA INFUSION (ELASTOMERIC) PUMPS MARKET 15
- 1.4 LIMITATIONS 17
- 1.5 MARKETS COVERED 17
2 MARKET SEGMENTATION 20
- 2.1 MARKETS COVERED 20
- 2.2 GEOGRAPHICAL SCOPE 21
- 2.3 YEARS CONSIDERED FOR THE STUDY 21
- 2.4 CURRENCY AND PRICING 21
- 2.5 DBMR TRIPOD DATA VALIDATION MODEL 22
- 2.6 MULTIVARIATE MODELLING 25
- 2.7 SERVICES LIFELINE CURVE 25
- 2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 26
- 2.9 DBMR MARKET POSITION GRID 27
- 2.10 MARKET APPLICATION COVERAGE GRID 28
- 2.11 SECONDARY SOURCES 29
- 2.12 ASSUMPTIONS 29
3 EXECUTIVE SUMMARY 30
4 PREMIUM INSIGHTS 32
- 4.1 NUMBER OF CITIES AND POPULATION IN SAUDI ARABIA 33
- 4.2 NAME OF HOSPITALS IN SAUDI ARABIA 36
- 4.3 INDUSTRIAL INSIGHTS: 42
- 4.4 PESTEL ANALYSIS 43
- 4.5 PORTER'S FIVE FORCES 44
5 EPIDEMIOLOGY 45
- 5.1 PREVALENCE OF CANCER IN THE MIDDLE EAST AND AFRICA 45
- 5.2 DIAGNOSIS RATE BY GENDER 45
- 5.3 MORTALITY BY GENDER 45
- 5.4 PREVALENCE OF DIABETES: 45
- 5.5 DIAGNOSIS RATE OF TYPE 2 DIABETES MELLITUS IN URBAN AREA 46
- 5.6 MORTALITY RATE IN AFRICAN COUNTRIES: 46
- 5.7 PREVALENCE OF GASTROINTESTINAL DISEASE IN THE MIDDLE EAST AND AFRICA REGION 46
- 5.8 GASTROINTESTINAL DISEASES ARE IN GREATER EFFECT IN POOR COUNTRIES 47
- 5.9 LOWER AND UPPER GASTROINTESTINAL DISORDER AND DISEASE PREVALENCE IN NIGERIA 47
- 5.10 PREVALENCE OF CHRONIC PAIN IN THE MIDDLE EAST AND AFRICA REGION 48
6 MARKET OVERVIEW 49
- 6.1 DRIVERS 51
- 6.1.1 INCREASED INCIDENCE OF CHRONIC DISEASES 51
- 6.1.2 INCREASED TECHNOLOGICAL ADVANCEMENTS IN INFUSION (ELASTOMERIC) PUMPS 51
- 6.1.3 INCREASED ADOPTION OF AMBULATORY PUMPS IN-HOME CARE SETTINGS 52
- 6.2 RESTRAINTS 52
- 6.2.1 FLUCTUATING COST ASSOCIATED WITH INFUSION (ELASTOMERIC) PUMPS SYSTEM 52
- 6.2.2 SIDE-EFFECTS OF INFUSION (ELASTOMERIC) PUMPS SYSTEM 53
- 6.2.3 STRINGENT GOVERNMENT REGULATION 53
- 6.3 OPPORTUNITIES 54
- 6.3.1 STRATEGIC INITIATIVES BY THE MARKET PLAYERS 54
- 6.3.2 RISING HEALTHCARE EXPENDITURE 54
- 6.3.3 RISING GOVERNMENT INITIATIVES TOWARD SAFETY 55
- 6.3.4 RISING IMPLEMENTATION OF SMALL HOSPITALS AND CLINICS 55
- 6.4 CHALLENGES 56
- 6.4.1 PRODUCT RECALLS 56
- 6.4.2 RISING COMPETITION BETWEEN MARKET PLAYERS 56
7 MIDDLE EAST AND AFRICA INFUSION (ELASTOMERIC) PUMPS MARKET, BY PRODUCT TYPE 57
- 7.1 OVERVIEW 58
- 7.2 ELASTOMERIC INFUSION PUMPS 61
- 7.2.1 BY TYPE 61
- 7.2.1.1 CONTINUOUS RATE ELASTOMERIC PUMPS 61
- 7.2.1.2 VARIABLE RATE ELASTOMERIC PUMPS 61
- 7.2.2 BY RATE 61
- 7.2.2.1 MULTI-RATE PUMPS 61
- 7.2.2.2 SINGLE RATE PUMPS 62
- 7.3 ACCESSORIES AND CONSUMABLES 62
- 7.3.1 INFUSION CATHETERS 62
- 7.3.2 BAG 62
- 7.3.2.1 BELT BAG 63
- 7.3.2.2 MESH BAG 63
- 7.3.3 OTHER ACCESSORIES AND CONSUMABLES 63
8 MIDDLE EAST AND AFRICA INFUSION (ELASTOMERIC) PUMPS MARKET, BY ROUTE OF ADMINISTRATION 64
- 8.1 OVERVIEW 65
- 8.2 INTRAVENOUS (IV) 68
- 8.3 SUBCUTANEOUS 68
- 8.4 EPIDURAL 68
- 8.5 INTRAMUSCULAR 68
9 MIDDLE EAST AND AFRICA INFUSION (ELASTOMERIC) PUMPS MARKET, BY APPLICATION 69
- 9.1 OVERVIEW 70
- 9.2 PAIN MANAGEMENT 73
- 9.2.1 POST-OPERATIVE PAIN MANAGEMENT 73
- 9.2.2 CANCER PAIN MANAGEMENT 73
- 9.2.3 OTHERS 73
- 9.3 ANTIBIOTIC/ANTIVIRAL THERAPY 73
- 9.3.1 CYSTIC FIBROSIS 74
- 9.3.2 OSTEOMYELITIS 74
- 9.3.3 HIV 74
- 9.3.4 OTHERS 74
- 9.4 CHEMOTHERAPY 74
- 9.5 THALASSEMIA TREATMENT 74
- 9.6 DIURETICS TREATMENT 75
- 9.7 LONG TERM INFUSION TREATMENT 75
- 9.8 OTHER APPLICATIONS 75
10 MIDDLE EAST AND AFRICA INFUSION (ELASTOMERIC) PUMPS MARKET, BY END USER 76
- 10.1 OVERVIEW 77
- 10.2 HOSPITALS 80
- 10.2.1 ACUTE CARE HOSPITALS 80
- 10.2.2 LONG TERM HOSPITALS 80
- 10.2.3 OTHERS 80
- 10.3 HOMECARE SETTINGS 80
- 10.4 AMBULATORY SURGICAL CENTERS 80
- 10.5 ACADEMIC AND RESEARCH INSTITUTES 81
- 10.6 SPECIALTY CLINICS 81
- 10.7 OTHERS 81
11 MIDDLE EAST AND AFRICA INFUSION (ELASTOMERIC) PUMPS MARKET, BY DISTRIBUTION CHANNEL 82
- 11.1 OVERVIEW 83
- 11.2 DIRECT TENDER 86
- 11.3 RETAIL SALES 86
- 11.4 ONLINE SALES 86
- 11.5 OTHERS 86
12 MIDDLE EAST AND AFRICA INFUSION (ELASTOMERIC) PUMPS MARKET, BY COUNTRY 87
- 12.1 SOUTH AFRICA 95
- 12.2 SAUDI ARABIA 99
- 12.3 U.A.E. 103
- 12.4 EGYPT 107
- 12.5 ISRAEL 111
- 12.6 REST OF MIDDLE EAST AND AFRICA 115
13 MIDDLE EAST AND AFRICA INFUSION (ELASTOMERIC) PUMPS MARKET: COMPANY LANDSCAPE 116
- 13.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA 116
14 SWOT ANALYSIS 117
15 COMPANY PROFILES 118
- 15.1 B. BRAUN SE 118
- 15.1.1 COMPANY SNAPSHOT 118
- 15.1.2 PRODUCT PORTFOLIO 118
- 15.1.3 RECENT DEVELOPMENTS 119
- 15.2 BAXTER 120
- 15.2.1 COMPANY SNAPSHOT 120
- 15.2.2 PRODUCT PORTFOLIO 120
- 15.2.3 RECENT DEVELOPMENTS 121
- 15.3 WERFEN 122
- 15.3.1 COMPANY SNAPSHOT 122
- 15.3.2 PRODUCT PORTFOLIO 122
- 15.3.3 RECENT DEVELOPMENT 122
- 15.4 NIPRO 123
- 15.4.1 COMPANY SNAPSHOT 123
- 15.4.2 PRODUCT PORTFOLIO 123
- 15.4.3 RECENT DEVELOPMENT 123
- 15.5 ICU MEDICAL 124
- 15.5.1 COMPANY SNAPSHOT 124
- 15.5.2 PRODUCT PORTFOLIO 124
- 15.5.3 RECENT DEVELOPMENT 125
- 15.6 AVNS 126
- 15.6.1 COMPANY SNAPSHOT 126
- 15.6.2 PRODUCT PORTFOLIO 126
- 15.6.3 RECENT DEVELOPMENT 126
- 15.7 EPIC MEDICAL 127
- 15.7.1 COMPANY SNAPSHOT 127
- 15.7.2 PRODUCT PORTFOLIO 127
- 15.7.3 RECENT DEVELOPMENT 127
16 QUESTIONNAIRE 128
17 RELATED REPORTS 132